ResearcherKorea Research Institute of Bioscience and BiotechnologyActive in the last 2 years

Kyunghee Noh

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0009-0006-9898-1100; OpenAlex author ID A5108620146. Sources: OpenAlex.

Their work

Papers: 2 (first author 2, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2025: 1 paper · 2026: 1 paper

Papers 2

From Amphiphiles to mRNA platforms: emerging vaccination strategies for pancreatic cancer. First author DOI 10.1186/s40164-026-00755-7 ↗
Advancing pancreatic cancer therapy by mesothelin-specific nanobody conjugation. First author DOI 10.1186/s12943-025-02325-7 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Dong Gun Lee · 1 shared paper, 2026 · strength 0.63
- Paper From Amphiphiles to mRNA platforms: emerging vaccination strategies for pancreatic cancer. DOI 10.1186/s40164-026-00755-7 ↗
Soyeon Yi · 1 shared paper, 2025 · strength 0.21
- Paper Advancing pancreatic cancer therapy by mesothelin-specific nanobody conjugation. DOI 10.1186/s12943-025-02325-7 ↗
Juyeon Jung · 1 shared paper, 2025 · strength 0.21
- Paper Advancing pancreatic cancer therapy by mesothelin-specific nanobody conjugation. DOI 10.1186/s12943-025-02325-7 ↗
Seok‐Ho Kim · 1 shared paper, 2025 · strength 0.21
- Paper Advancing pancreatic cancer therapy by mesothelin-specific nanobody conjugation. DOI 10.1186/s12943-025-02325-7 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.